Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Association of OCT and OCT angiography measures with the development and worsening of diabetic retinopathy in type 2 diabetes

Abstract

Objective

To assess if optical coherence tomography (OCT) and OCT angiography (OCTA) measures are associated with the development and worsening of diabetic retinopathy (DR) over four years.

Methods

280 participants with type 2 diabetes underwent ultra-wide field fundus photography, OCT and OCTA. OCT-derived macular thickness measures, retinal nerve fibre layer and ganglion cell-inner plexiform layer thickness and OCTA-derived foveal avascular zone area, perimeter, circularity, vessel density (VD) and macular perfusion (MP) were examined in relation to the development and worsening of DR over four years.

Results

After four years, 206 eyes of 219 participants were eligible for analysis. 27 of the 161 eyes (16.7%) with no DR at baseline developed new DR, which was associated with a higher baseline HbA1c and longer diabetes duration. Of the 45 eyes with non-proliferative DR (NPDR) at baseline, 17 (37.7%) showed DR progression. Baseline VD (12.90 vs. 14.90 mm/mm2, p = 0.032) and MP (31.79% vs. 36.96%, p = 0.043) were significantly lower in progressors compared to non-progressors. Progression of DR was inversely related to VD ((hazard ratio [HR] = 0.825) and to MP (HR = 0.936). The area under the receiver operating characteristic curves for VD was AUC = 0.643, with 77.4% sensitivity and 41.8% specificity for a cut-off of 15.85 mm/mm2 and for MP it was AUC = 0.635, with 77.4% sensitivity and 25.5% specificity for a cut-off of 40.8%.

Conclusions

OCTA metrics have utility in predicting progression rather than the development of DR in individuals with type 2 diabetes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Similar content being viewed by others

Data availability

Data are available from the first author upon reasonable request.

References

  1. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Investig. 1998;102:783–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. de Carlo TE, Chin AT, Bonini Filho MA, Adhi M, Branchini L, Salz DA, et al. Detection of microvascular changes in eyes of patients with diabetes but not clinical diabetic retinopathy using optical coherence tomography angiography. Retina. 2015;35:2364–70.

    Article  PubMed  Google Scholar 

  3. Dimitrova G, Chihara E, Takahashi H, Amano H, Okazaki K. Quantitative retinal optical coherence tomography angiography in patients with diabetes without diabetic retinopathy. Investig Opthalmol Vis Sci. 2017;58:1766.

    Article  Google Scholar 

  4. Takase N, Nozaki M, Kato A, Ozeki H, Yoshida M, Ogura Y, et al. Enlargement of foveal avascular zone in diabetic eyes evaluated by en face optical coherence tomography angiography. Retina. 2015;35:2377–83.

    Article  PubMed  Google Scholar 

  5. Mastropasqua R, Toto L, Mastropasqua A, Aloia R, De Nicola C, Mattei PA, et al. Foveal avascular zone area and parafoveal vessel density measurements in different stages of diabetic retinopathy by optical coherence tomography angiography. Int J Ophthalmol. 2017;10:1545–51.

    PubMed  PubMed Central  Google Scholar 

  6. Kirthi V, Reed KI, Alattar K, Zuckerman BP, Bunce C, Nderitu P, et al. Multimodal testing reveals subclinical neurovascular dysfunction in prediabetes, challenging the diagnostic threshold of diabetes. Diabetic Med. 2022. https://doi.org/10.1111/DME.14952.

  7. Sun Z, Tang F, Wong R, Lok J, Szeto SKH, Chan JCK, et al. OCT angiography metrics predict progression of diabetic retinopathy and development of diabetic macular edema. Ophthalmology. 2019;126:1675–84.

    Article  PubMed  Google Scholar 

  8. Bressler NM, Edwards AR, Antoszyk AN, Beck RW, Browning DJ, Ciardella AP, et al. Diabetic Retinopathy Clinical Research Network. Retinal thickness on stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. Am. J. Ophthalmol. 2008;145:894–901.

  9. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol. 1985;103:1796–806.

    Article  Google Scholar 

  10. Diabetic Retinopathy Clinical Research Network, Krzystolik MG, Strauber SF, Aiello LP, Beck RW, Berger BB, Bressler NM, et al. Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology. 2007;114:1520–5.

    Article  Google Scholar 

  11. Marques IP, Ferreira S, Santos T, Madeira MH, Santos AR, Mendes L, et al. Association between neurodegeneration and macular perfusion in the progression of diabetic retinopathy: a 3-Year Longitudinal Study. Ophthalmologica. 2022;245:335–41.

    Article  CAS  PubMed  Google Scholar 

  12. Tombolini B, Borrelli E, Sacconi R, Bandello F, Querques G. Diabetic macular ischemia. Acta Diabetol. 2022;59:751–9.

    Article  PubMed  Google Scholar 

  13. Boned-Murillo A, Albertos-Arranz H, Diaz-Barreda MD, Orduna-Hospital E, Sánchez-Cano A, Ferreras A, et al. Optical coherence tomography angiography in diabetic patients: a systematic review. Biomedicines. 2021;10:88.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Early Treatment Diabetic Retinopathy Study Research Group. Fluorescein angiographic risk factors for progression of diabetic retinopathy: ETDRS report number 13. Ophthalmology. 1991;98:834–40.

    Article  Google Scholar 

  15. Ludovico J, Bernardes R, Pires I, Figueira J, Lobo C, Cunha-Vaz J. Alterations of retinal capillary blood flow in preclinical retinopathy in subjects with type 2 diabetes. Graefe’s Arch Clin Exp Ophthalmol. 2003;241:181–6.

    Article  Google Scholar 

  16. Durbin MK, An L, Shemonski ND, Soares M, Santos T, Lopes M, et al. Quantification of retinal microvascular density in optical coherence tomographic angiography images in diabetic retinopathy. JAMA Ophthalmol. 2017;135:370–6.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Santos T, Warren LH, Santos AR, Marques IP, Kubach S, Mendes LG, et al. Swept-source OCTA quantification of capillary closure predicts ETDRS severity staging of NPDR. Br J Ophthalmol. 2022;106:712–8.

    Article  PubMed  Google Scholar 

  18. Marques IP, Kubach S, Santos T, Mendes L, Madeira MH, de Sisternes L, et al. Optical coherence tomography angiography metrics monitor severity progression of diabetic retinopathy—3-Year Longitudinal study. J Clin Med. 2021;10:2296.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Custo Greig E, Brigell M, Cao F, Levine ES, Peters K, Moult EM, et al. Macular and peripapillary optical coherence tomography angiography metrics predict progression in diabetic retinopathy: a sub-analysis of TIME-2b study data. Am J Ophthalmol. 2020;219:66–76.

    Article  PubMed  Google Scholar 

  20. Ratra D, Dalan D, Prakash N, Kaviarasan K, Thanikachalam S, Das UN, et al. Quantitative analysis of retinal microvascular changes in prediabetic and diabetic patients. Indian J Ophthalmol. 2021;69:3226–34.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Guo X, Chen Y, Bulloch G, Xiong K, Chen Y, Li Y, et al. Guangzhou Diabetic Eye Study Group. Parapapillary choroidal microvasculature predicts diabetic retinopathy progression and diabetic macular edema development: a three-year prospective study. Am J Ophthalmol. 2022:245:164–73.

  22. Wang W, Cheng W, Yang S, Chen Y, Zhu Z, Huang W. Choriocapillaris flow deficit and the risk of referable diabetic retinopathy: a longitudinal SS-OCTA study. Br J Ophthalmol. 2022:bjophthalmol-2021-320704. https://doi.org/10.1136/bjophthalmol-2021-320704. Online ahead of print.

Download references

Funding

This work was supported by the DBT/Wellcome Trust India Alliance Fellowship [grant number IA/CPHE/16/1/502670] awarded to Sangeetha Srinivasan.

Author information

Authors and Affiliations

Authors

Contributions

SS, RRN, MPB involved in conceptualization of the study; SS involved in data analysis; SS, MPB involved in the drafting of the manuscript; SS, SSD, RR, RMA, RAM, VK, RRN, MPB involved in interpretation of results and in critical review of the manuscript.

Corresponding author

Correspondence to Muna Bhende.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Srinivasan, S., Sivaprasad, S., Rajalakshmi, R. et al. Association of OCT and OCT angiography measures with the development and worsening of diabetic retinopathy in type 2 diabetes. Eye 37, 3781–3786 (2023). https://doi.org/10.1038/s41433-023-02605-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41433-023-02605-w

This article is cited by

Search

Quick links